UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Adrenal function in sepsis: The retrospective Corticus cohort study

Critical care medicine, 2007-04, Vol.35 (4), p.1012-1018

2007

Volltextzugriff (PDF)

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

The New England journal of medicine, 2001-03, Vol.344 (10), p.699-709

2001

Volltextzugriff (PDF)

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Critical care medicine, 2005-05, Vol.33 (5), p.952-961

2005

Volltextzugriff (PDF)

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The New England journal of medicine, 2004-08, Vol.351 (9), p.884-892

2004

Volltextzugriff (PDF)

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

ERJ open research, 2023-01, Vol.9 (1), p.342

2023

Volltextzugriff (PDF)

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Thorax, 2014-11, Vol.69 (11), p.1034-1042

2014

Volltextzugriff (PDF)

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (9), p.1024-1034

2021

Volltextzugriff (PDF)

Convalescent Plasma for Covid-19-Induced ARDS. Reply

The New England journal of medicine, 2024-01, Vol.390 (4), p.386-386

2024

Volltextzugriff (PDF)

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2019-06, Vol.19 (6), p.620-630

2019

Volltextzugriff (PDF)

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Critical care medicine, 2018-09, Vol.46 (9), p.1436-1443

2018

Volltextzugriff (PDF)

The INHALE trial: multiple reasons for a negative result

The Lancet infectious diseases, 2020-07, Vol.20 (7), p.778-779

2020

Volltextzugriff (PDF)

Immunotherapies for COVID-19: lessons learned from sepsis

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.946-949

2020

Volltextzugriff (PDF)

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

PloS one, 2016-05, Vol.11 (5), p.e0156299-e0156299

2016

Volltextzugriff (PDF)

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Critical care medicine, 2004-02, Vol.32 (2), p.332-341

2004

Volltextzugriff (PDF)

Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients

The New England journal of medicine, 2023-10, Vol.389 (17), p.1590-1600

2023

Volltextzugriff (PDF)

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine

Anaesthesia critical care & pain medicine, 2022-06, Vol.41 (3), p.101103-101103, Article 101103

2022

Volltextzugriff (PDF)

sTREM-1 is a specific biomarker of TREM-1 pathway activation

Cellular & molecular immunology, 2021-08, Vol.18 (8), p.2054-2056

2021

Volltextzugriff (PDF)

Monotherapy or Combination Therapy for Hospitalized Patients with Community-Acquired Pneumonia: Not Yet the End of the Story?

Clinical infectious diseases, 2008-05, Vol.46 (10), p.1510-1512

Laterre, Pierre-Francois

2008

Volltextzugriff (PDF)

Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19

Scientific reports, 2022-06, Vol.12 (1), p.9959-9959, Article 9959

2022

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

Shock (Augusta, Ga.), 2018-04, Vol.49 (4), p.385-392

2018

Volltextzugriff (PDF)

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

BMJ open, 2019-02, Vol.9 (2), p.e024475

2019

Volltextzugriff (PDF)

Selepressin for Patients With Septic Shock-Reply

JAMA : the journal of the American Medical Association, 2020-02, Vol.323 (7), p.667

2020

Volltextzugriff (PDF)

Open Lung Biopsy in Nonresolving Acute Respiratory Distress Syndrome Commonly Identifies Corticosteroid-Sensitive Pathologies, Associated With Better Outcome

Critical care medicine, 2018-06, Vol.46 (6), p.907-914

2018

Volltextzugriff (PDF)

Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

EBioMedicine, 2022-03, Vol.77, p.103893-103893, Article 103893

2022

Volltextzugriff (PDF)

What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling

International journal of antimicrobial agents, 2020-10, Vol.56 (4), p.106113, Article 106113

2020

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Complete Journals

KollektionSpringerLink (Online service)

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(158)
Japanisch
(16)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adrenal function in sepsis: The retrospective Corticus cohort study

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

Convalescent Plasma for Covid-19-Induced ARDS. Reply

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

The INHALE trial: multiple reasons for a negative result

Immunotherapies for COVID-19: lessons learned from sepsis

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine

sTREM-1 is a specific biomarker of TREM-1 pathway activation

Monotherapy or Combination Therapy for Hospitalized Patients with Community-Acquired Pneumonia: Not Yet the End of the Story?

Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

Selepressin for Patients With Septic Shock-Reply

Open Lung Biopsy in Nonresolving Acute Respiratory Distress Syndrome Commonly Identifies Corticosteroid-Sensitive Pathologies, Associated With Better Outcome

Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling

Aktive Filter

Suchergebnisse filtern